Protease composition and method for treating a digestive disorder
AssigneeNational Enzyme Company
InventorsJohn G. Davidson, Rohit Medhekar, Jeremy Moore, Ken Paydon, Steve Marr
Life of this patent
Estimating the term…
Abstract
There is provided methods, kits, combinations, and compositions comprising a Aspergillus oryzae protease enzyme, a Bacillus subtilis protease enzyme, and a Aspergillus niger lipase enzyme for treating a digestive disorder in a subject in need thereof. The methods, kits, combinations, and compositions may also be used along with an agent (or combination of agents) for raising the gastric pH, a digestive enzyme useful in enhancing digestive activity, a dietary supplement, or a pharmaceutical agent.
Claims43
A composition, comprising:
- (a) at least about 500 HUT Aspergillus oryzae protease enzyme;
- (b) at least about 750 PC Bacillus subtilis protease enzyme;
- and
- (c) at least about 10 FCCLU Aspergillus niger lipase enzyme.
A method for treating or reducing the risk of developing a digestive disorder in a subject in need thereof, comprising:
- administering to the subject a digestive disorder effective amount of a composition which comprises:
- (a)at least about 500 HUT Aspergillus oryzae protease enzyme;
- (b)at least about 750 PC Bacillus subtilis protease enzyme;
- and
- (c) at least about 10 FCCLU Aspergillus niger lipase enzyme.
A method for treating or reducing the risk of developing a digestive disorder in a subject in need thereof, comprising:
- administering to the subject in a combination therapy at least about 500 HUT Aspergillus oryzae protease enzyme, at least about 750 PC Bacillus subtilis protease enzyme, at least about 10 FCCLU Aspergillus niger lipase enzyme, and an agent selected from the group consisting of an antacid, an H2 receptor antagonist and a proton pump inhibitor.
Dependencies are inferred from the claim text.